Sripad Ram heads the digital pathology and image analysis group in Drug Safety R&D at Pfizer. His research interests include digital scoring of IHC biomarkers, AI/ML algorithm development for whole-slide image analysis, and the development of 3D imaging and image-analysis tools for histopathology specimens. He received his PhD in Bioengineering from UT Southwestern Medical Center and continued his postdoctoral research at the same institution as a National Multiple Sclerosis Society Postdoctoral Fellow. Prior to joining Pfizer, he worked at Carl Zeiss Inc as a microscopy systems specialist.